System and method for detecting tissue state and infection during electrosurgical treatment of wound tissue
AssigneeArthroCare Corporation
InventorsJean Woloszko, Thomas P. Ryan, Kenneth R. Stalder
Life of this patent
Estimating the term…
Abstract
A method exposes a wound bed to electrosurgical treatment to generate fragmented wound tissue, gathers a molecular gaseous by-product sample of the fragmented wound tissue, and analyzes the molecular gaseous by-product sample of the fragmented wound tissue to generate a fragmented wound tissue compound analysis profile. The method further compares the fragmented wound tissue compound analysis profile with a database of known compound analysis profiles and provides a diagnosis of the wound tissue based on the comparison of compound analysis profiles.
Claims79
A method comprising:
- exposing a wound bed to electrosurgical treatment to generate fragmented wound tissue in situ;
- gathering a molecular gaseous by-product sample of the fragmented wound tissue;
- analyzing the molecular gaseous by-product sample of the fragmented wound tissue to generate a fragmented wound tissue compound analysis profile;
- comparing the fragmented wound tissue compound analysis profile with a database of known compound analysis profiles;
- and
- providing a diagnosis of the wound tissue based on the comparison of compound analysis profiles.
A method comprising:
- gathering a molecular gaseous sample emitted from a location on a wound bed after electrosurgical treatment of the wound tissue location;
- analyzing the molecular gaseous sample emitted from a location on a wound bed after electrosurgical treatment to generate a post-treatment compound analysis profile;
- comparing the post-treatment compound analysis profile with a database of known compound analysis profiles;
- and
- providing a diagnosis of the wound bed location based on a comparison of the compound analysis profiles.
A system for electrosurgically treating tissue comprising:
- an electrosurgical treatment mechanism to provide electrosurgical treatment to a target tissue wherein the target tissue is fragmented;
- a sampling aperture to gather a molecular gaseous by-product sample of tissue fragmentation;
- a sensor in fluid communication with the sampling aperture to detect compounds from a molecular gaseous by-product sample of tissue fragmentation;
- a processor to determine a fragmented target tissue compound analysis profile;
- and
- the processor comparing the fragmented target tissue compound profile with a database of known compound analysis profiles resulting from the target tissue fragmentation.
A system for diagnosing treated tissue comprising:
- a sampling aperture to gather a molecular gaseous sample of target tissue fragmented by electrosurgical or non-electrosurgical treatment;
- a sensor in fluid communication with the sampling aperture to detect compounds from a sample of the molecular gaseous by-product of target tissue fragmentation;
- a processor to determine a fragmented target tissue compound analysis profile;
- and
- the processor to compare the compound profile with a database of known compound analysis profiles resulting from the target tissue fragmentation.
A system for diagnosing electrosurgically treated tissue comprising:
- a sampling aperture to gather a molecular gaseous by-product sample of target tissue fragmented by electrosurgical treatment;
- a sensor in fluid communication with the sampling aperture to detect compounds from a sample of the molecular gaseous by-product of tissue fragmentation;
- a processor to determine a fragmented target tissue compound analysis profile;
- and
- the processor to subtract out one or more data signatures specific to electrosurgical treatment of the target tissue from the fragmented target tissue compound analysis profile resulting in a diagnostic compound analysis profile;
- the processor to compare the diagnostic compound profile with a database of known compound analysis profiles.
A system for diagnosing electrosurgically treated tissue comprising:
- a sampling aperture to gather a molecular gaseous sample emitted from a location on a target tissue bed for a compound analysis after electrosurgical treatment of a target tissue location;
- a sensor in fluid communication with the sampling aperture to detect compounds from the molecular gaseous sample emitted from a location on the target tissue bed;
- and
- a processor to compare a post-treatment compound analysis profile of the molecular gaseous sample emitted from the target tissue bed with a database of known compound analysis profiles resulting from post-electrosurgical treatment,
- wherein the comparison is provided to assist in determination of a disease state of the target tissue bed location after the electrosurgical treatment.
The system of claim 68, further comprising:
- a treatment site navigation detector to determine target tissue locations in a target tissue bed;
- the processor to compare the post-treatment compound analysis profile with the pre-treatment compound analysis profile at a plurality of target tissue bed locations to determine the change in disease state of the target tissue bed over the plurality of target bed locations.
A method comprising:
- segmenting a wound bed into wound bed location zones identified by a treatment site navigation detector;
- gathering molecular gaseous samples emitted from the plurality of wound bed locations;
- analyzing the molecular gaseous samples emitted from a plurality of wound bed location zones on a wound bed to generate a plurality compound analysis profiles for the plurality of wound bed location zones;
- providing diagnoses for the plurality wound bed location zones;
- and
- mapping the diagnoses for the plurality wound bed location zones, wherein the diagnoses mapping is provided to assist in determination of a disease state of the wound bed for treatment.
Dependencies are inferred from the claim text.